Abstract
This study was performed in order to gain insight into the occurrence, glycosylation and the possible origin of the acute-phase proteins α1-acid glycoprotein (AGP) and α1-protease inhibitor (PI) in sera and synovial fluid from patients with rheumatoid arthritis (RA). Therefore paired sera and synovial fluid samples from patients with RA, and paired synovial fluid samples from right and left knees of patients with varying degrees of arthritis were studied. Crossed affinity immunoelectrophoresis (CAIE) was used with concanavalin A and Aleuria aurantia lectin for the detection of the degree of branching and fucosylation, respectively, and the monoclonal CSLEX-1 for the detection of Sialyl Lewisx (SLex) groups on AGP. For PI, not only CAIE, but also high-pressure-anion-exchange chromatography with pulsed amperometric detection was used to study the glycosylation. It was established that the concentrations of AGP and PI were increased in the serum of RA patients compared to normal healthy controls, but that the concentration of both proteins, as well as albumin, was significantly lower in synovial fluid than in serum. Furthermore, the type of glycosylation of both AGP and PI found in RA was significantly different from that found in normals, with increased fucosylation, but there were no major differences in the degree of branching of AGP- or PI-glycans in RA, compared to normals. No differences in glycosylation could be established between serum and synovial fluid in RA. For PI an increased fucosylation was found, both in serum and synovial fluid, using both methods of detection, and it could be established that only the α1→3- and not the α1→6-fucosylation of PI was affected by RA. The increased fucosylation of AGP resulted in an increased expression of SLex on AGP-glycans. Since the α1→3- fucosylation of AGP was significantly increased in both serum and synovial fluid from RA patients, and this correlated with systemic but not with local disease parameters, it can be suggested that acute phase proteins in synovial fluid are most probably of hepatic origin. Abbreviations: AGP, α1-acid glycoprotein; AAL, Aleuria Aurantia Lectin; Con A, concanavalin A; PI, α1-protease inhibitor; CAIE, crossed affino-immunoelectrophoresis; SLex, sialyl Lewis X; IL-6, interleukin-6; RA, rheumatoid arthritis; PMN, polymorphonuclear cells; HPAEC, high pressure anion exchange chromatography
Similar content being viewed by others
References
Baumann, H and Gauldie J (1994) Immunol Today 15: 74-80.
Baumann H (1989) In vitro Cell Develop Biol 25: 115-26.
Van Dijk W, Turner GA and Mackiewicz A (1994) Glycosylation and Disease 1: 5-14.
De Graaf TW, Van der Stelt ME, Anbergen MG and Van Dijk W (1993) J Exp Med 177: 657-66.
Van Dijk W, Havenaar EC, Brinkman-Van der Linden ECM (1995) Glycoconjugate J 12: 227-33.
Brinkman-Van der Linden ECM, Van Ommen ECR, Van Dijk W (1996) Glycoconjugate J 13: 27-31.
de Graaf TW, Van Ommen ECR, Van der Stelt ME, Kerstens PJSM, Boerbooms AMT, Van Dijk W (1994) J Rheumatol 21: 2209-16.
Havenaar EC, Drenth JPH, Van Ommen ECR, Van der Meer JWM, Van Dijk W (1995) Clin Immunol Immunopathol 76: 279-84.
Mackiewicz A, Pawlowski T, Mackiewicz-Pawlowska A, Wiktorowicz K, Mackiewicz S (1987) Clin Chim Acta 163: 185-90.
Dargan E, Thompson S, Cantwell BMJ, Wilson RG, Turner GA (1994). Glycosylation and Disease 1: 37-43.
Thompson S, Kelly CA, Gri¦ths ID, Turner GA (1989) Clin Chim Acta 184: 251-58.
Thompson S, Dargan E, Gri¦ths ID, Kelly CA, Turner GA (1993) Clin Chim Acta 220: 107-14.
Springer TA, Lasky LA (1991) Nature 349: 196-7.
Feizi T (1992) Biochem Soc Trans 20: 274-8.
Gahmberg CG, Andersson LC (1978) J Exp Med 148: 507-12.
Perlmutter DH (1993) In: Acute Phase Proteins (Mackiewicz A, Kushner I, Baumann H eds) pp 150-67. London: CRC Press.
Carell RW (1990) Lung 168: S530-34.
Arnett FC, Edworthy SM, Bloch DA et al. (1988) Arthritis Rheum 31: 315-24.
Ritchie DM, Boyle JA, McInnes JM et al. (1968). Q J Med 147: 393-406.
Heijde vd DMFM, Van't Hof MA, Van Riel PLCM et al. (1990) Ann Rheum Dis 49: 916-20.
Miltenburg AMM, Van Laar JM, de Kuiper R et al. (1991) Brit J Rheumatol 30: 186-89.
Mancini G, Carbonara AO, Heremans JF (1965) Immunochemistry 2: 235-54.
Bøg-Hansen TC. (1973) Anal Biochem 56: 480-88.
Saitoh A, Aoyagi Y, Asakura H (1993) Arch Biochem Biophys 303: 281-87.
Laurell C.B. (1966) Anal Biochem 15: 45-52.
Laemmli UK (1970) Nature 227: 680-85.
Hao YL, Wickerhauser M (1973) Biochim Biophys Acta 322: 99-108
Fukushima K., Hirota M., Terasaki PI et al. (1984) Cancer Res 44: 5279-85.
Goodarzi MT, Turner GA (1995) Clin Chim Acta 236: 161-71.
Brinkman-Van der Linden ECM, Mollicone R, Oriol R, Larson G, Van den Eijnden DH, Van Dijk W (1996) J Biol Chem 273: 14492-95.
Nakamura T, Board PG, Matsushita K et al. (1993) Inflammation 17: 33-45.
Moule SK, Peak M, Thompson S, Turner GA (1987) Clin Chim Acta 166: 177-85.
Pawlowski T, Mackiewicz A (1989) In: Alpha-1-acid Glycoprotein: Genetics, Biochemistry, Physiological Functions and Pharmacology (Baumann P, Eap CB, Mu¬ ller WE, Tillemenet JP eds) pp 223-26. New York: AR Liss.
Paulson JC, Prieels J-P, Glasgow LR, Hill RL (1978) J Biol Chem 253: 5617-24.
de Vries T, Srnka CA, Palcic MM, Swiedler SJ, Van den Eijnden DH, Macher BA (1995) J Biol Chem 270: 8712-22.
Nemansky M, Schiphorst WECM, Van den Eijnden DH (1995) FEBS ¸ett 363: 280-84.
Mackiewicz A, Schultz D, Mathison J, Ganapathi MK, Kushner I (1989) Clin Exp Immunol 75: 70-75.
Mackiewicz A, Ganapathi MK, Schultz D, Kushner I (1987) J Exp Med 166: 253-58.
Pos O, Moshage HJ, Yap SH, Snieders JPM, Aarden LA, Van Gool J, Boers W, Brugman AM, Van Dijk W (1989) Inflammation 13: 415-27.
Bennet M, Schmid K (1980) Proc Natl Acad Sci 77: 6109-13.
Pos O, Oostendorp RAJ, Van der Stelt ME, Scheper RJ, Van Dijk W (1990) Inflammation 14: 133-41.
Bories PN, Feger J, Benbernou N, Rouzeau J-D, Agneray J, Durand G (1990) Inflammation 14: 315-23.
Costello M, Fiedel BA, Gewurz H (1979) Nature 281: 677-8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Havenaar, E.C., Dolhain, R.J., Turner, G.A. et al. Do synovial fluid acute phase proteins from patients with rheumatoid arthritis originate from serum?. Glycoconj J 14, 457–465 (1997). https://doi.org/10.1023/A:1018547417702
Issue Date:
DOI: https://doi.org/10.1023/A:1018547417702